Increased upper and lower tract Urothelial carcinoma in patients with end-stage renal disease: A nationwide cohort study in Taiwan during 1997-2008

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wang, Shuo Meng ^a,b   Lai, Ming Nan ^c   Chen, Pau Chung ^b   Pu, Yeong Shiau ^a   Lai, Ming Kuen ^d   Hwang, Jing Shiang ^e   Wang, Jung Der ^f,g  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FENG CHIA UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^g NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CANCER INCIDENCE; END STAGE RENAL DISEASE; HUMAN; NATIONAL HEALTH INSURANCE; REIMBURSEMENT; REVIEW; SEX DIFFERENCE; TAIWAN; TRANSITIONAL CELL CARCINOMA; ADULT; AGED; CHRONIC KIDNEY FAILURE; COMPLICATION; EMBRYOLOGY; FEMALE; MALE; MIDDLE AGED; NEOPLASM; PATHOLOGY; UROTHELIUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEOPLASMS; TAIWAN; UROTHELIUM;

EID: 84904093889     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/149750     Document Type: Review

References (26)

1. Maisonneuve P., Agodoa L., Gellert R., Stewart J. H., Buccianti G., Lowenfels A. B., Wolfe R. A., Jones E., Disney A. P. S., Briggs D., McCredie M., Boyle P., Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. The Lancet 1999 354 9173 93 99 2-s2.0-0033542845 10.1016/S0140-6736(99)06154-1 (Pubitemid 29313142)
2. Akiyama T., Imanishi M., Matsuda H., Nishioka T., Kunikata S., Kurita T., Difference among races in posttransplant malignancies: report from an oriental country. Transplantation Proceedings 1998 30 5 2058 2059 2-s2.0-0031658887 10.1016/S0041-1345(98)00540-5 (Pubitemid 28399428)
3. Stewart J. H., Buccianti G., Agodoa L., Gellert R., McCredie M. R. E., Lowenfels A. B., Disney A. P. S., Wolfe R. A., Boyle P., Maisonneuve P., Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. Journal of the American Society of Nephrology 2003 14 1 197 207 2-s2.0-0037220959 10.1097/01.ASN.0000039608.81046.81 (Pubitemid 36026310)
4. Agraharkar M. L., Cinclair R. D., Kuo Y.-F., Daller J. A., Shahinian V. B., Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney International 2004 66 1 383 389 2-s2.0-3042808446 10.1111/j.1523-1755.2004.00741.x (Pubitemid 38870116)
5. Kuo H.-W., Tsai S.-S., Tiao M.-M., Yang C.-Y., Epidemiological features of CKD in Taiwan. American Journal of Kidney Diseases 2007 49 1 46 55 2-s2.0-33845587954 10.1053/j.ajkd.2006.10.007 (Pubitemid 44932195)
6. Collins A. J., Kasiske B., Herzog C., Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. American Journal of Kidney Diseases 2005 45 1, supplement 1 A5 A7
7. Lin H.-F., Li Y.-H., Wang C.-H., Chou C.-L., Kuo D.-J., Fang T.-C., Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan. Nephrology Dialysis Transplantation 2012 27 4 1585 1590 2-s2.0-84859334826 10.1093/ndt/gfr464
8. Zeegers M. P., Tan F. E., Dorant E., van den Brandt P. A., The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000 89 3 630 639 (Pubitemid 30640110)
9. Lai M.-N., Lai J.-N., Chen P.-C., Hsieh S.-C., Hu F.-C., Wang J.-D., Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study. American Journal of Kidney Diseases 2010 55 3 507 518 2-s2.0-77049088904 10.1053/j.ajkd.2009.10.055
10. Lai M.-N., Wang S.-M., Chen P.-C., Chen Y.-Y., Wang J.-D., Population-based case-control study of chinese herbal products containing aristolochic acid and urinary tract cancer risk. Journal of the National Cancer Institute 2010 102 3 179 186 2-s2.0-76349101626 10.1093/jnci/djp467
11. Rosner B., Fundamentals of Biostatistics 2010 7th Boston, Mass, USA Cengage Learning
12. IARC Monographs List of Classifications by Cancer Site 1996 Lyon, France International Agency for Research on Cancer. http://monographs.iarc.fr/ENG/ Classification/Table4.pdf
13. Fortuny J., Kogevinas M., Zens M. S., Schned A., Andrew A. S., Heaney J., Kelsey K. T., Karagas M. R., Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. BMC Urology 2007 7, article 13 2-s2.0-35348882103 10.1186/1471-2490-7-13 (Pubitemid 47579886)
14. Kaye J. A., Wald Myers M., Jick H., Acetaminophen and the risk of renal and bladder cancer in the general practice research database. Epidemiology 2001 12 6 690 694 2-s2.0-0035215408 10.1097/00001648-200111000-00018 (Pubitemid 33134532)
15. Genkinger J. M., DeVivo I., Stampfer M. J., Giovannucci E., Michaud D. S., Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study. International Journal of Cancer 2007 120 10 2221 2225 2-s2.0-34147124796 10.1002/ijc.22546 (Pubitemid 46555862)
16. van der Heijden A. G., Witjes J. A., Recurrence, progression, and follow-up in non-muscle-invasive bladder cancer. European Urology, Supplements 2009 8 7 556 562 2-s2.0-67651054951 10.1016/j.eursup.2009.06.010
17. Adult Smoking Behavior Surveillance System 2013 ASBS. http://tobacco.hpa.gov.tw/Show.aspx?MenuId=581
18. Kessler D. A., Cancer and herbs. The New England Journal of Medicine 2000 342 23 1742 1743 2-s2.0-0034622021 10.1056/NEJM200006083422309 (Pubitemid 30354523)
19. Nortier J. L., Martinez M.-C. M., Schmeiser H. H., Arlt V. M., Bieler C. A., Petein M., Depierreux M. F., De Pauw L., Abramowicz D., Vereerstraeten P., Vanherweghem J.-L., Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). The New England Journal of Medicine 2000 342 23 1686 1692 2-s2.0-0034622082 10.1056/NEJM200006083422301 (Pubitemid 30354515)
20. Lemy A., Wissing K. M., Rorive S., Zlotta A., Roumeguere T., Muniz Martinez M.-C., Decaestecker C., Salmon I., Abramowicz D., Vanherweghem J.-L., Nortier J., Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. American Journal of Kidney Diseases 2008 51 3 471 477 2-s2.0-39449104221 10.1053/j.ajkd.2007.11.015 (Pubitemid 351273477)
21. Hsieh S.-C., Lin I.-H., Tseng W.-L., Lee C.-H., Wang J.-D., Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chinese Medicine 2008 3, article 13 2-s2.0-56449129467 10.1186/1749-8546-3-13
22. Hsieh S.-C., Lai J.-N., Lee C.-F., Hu F.-C., Tseng W.-L., Wang J.-D., The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiology and Drug Safety 2008 17 6 609 619 2-s2.0-46349110645 10.1002/pds.1611 (Pubitemid 351982767)
23. Hsieh S.-C., Lai J.-N., Chen P.-C., Chen C.-C., Chen H.-J., Wang J.-D., Is Duhuo Jisheng Tang containing Xixin safe? A four-week safety study. Chinese Medicine 2010 5 1, article 6 2-s2.0-77649135451 10.1186/1749-8546-5-6
24. Chen C. H., Dickman K. G., Moriya M., Aristolochic acid-associated urothelial cancer in Taiwan. Proceedings of the National Academy of Sciences of the United States of America 2012 109 21 8241 8246 10.1073/pnas.1119920109
25. Hoang M. L., Chen C., Sidorenko V. S., He J., Dickman K. G., Yun B. H., Moriya M., Niknafs N., Douville C., Karchin R., Turesky R. J., Pu Y. S., Vogelstein B., Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Science Translational Medicine 2013 5 197 10 10.1126/scitranslmed.3006200
26. Kessler D. A., Cancer and herbs. The New England Journal of Medicine 2000 342 23 1742 1743 2-s2.0-0034622021 10.1056/NEJM200006083422309 (Pubitemid 30354523)